Covishield

Pune: As part of its effort to ramp up production and speed up the vaccination process in India, Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply 9 to 10 crore doses of Covishield in…

New Delhi: The Centre is going to make changes in the CoWIN app to increase the minimum period between the 1st and 2nd doses for Covishield vaccine from 42 days (6 weeks) to 84 days (12 weeks). The changes will be effective from midnight…

New Delhi: There should be a 12 to 16 weeks gap between two doses of Covishield COVID-19 vaccine to 12-16 weeks, the National Technical Advisory Group on Immunisation (NTAGI) recommended after a recent meeting. Pregnant women may be…

New Delhi: Following the confusion over the price of the COVID-19 vaccines — Covishield and Covaxin — the central government has declared that it will procure both the COVID-19 vaccines at Rs 150 per dose. The Ministry of Health and Family…

A rare blood clotting condition, after administration of the Oxford-AstraZeneca COVID vaccine, has been a cause of concern in the UK and other European Union countries. About 10 deaths have been recorded in the UK, most of them being cases…

New Delhi: The Serum Institute of India (SII) that is manufacturing the Covishield vaccine needs around Rs 3,000 crore and three months to scale up production, its CEO Adar Poonawalla told NDTV on Tuesday evening. SII had agreed to…

New Delhi: The Serum Institute of India (SII) has geared up to raise the output of Covishield vaccines by 67% to 100 million doses a month from May. The move comes in the backdrop of the increasing demand for vaccines in view of the fast…

New Delhi: A committee set up by the government on Monday, allayed the fear of people that Covishield and Covaxin increase the risk of blood clotting. The committee submitted its findings after analysing over 400 major adverse reactions…

New Delhi: India has decided to review the hospitalisations and deaths in people who took Covishield vaccine. The step comes after at least 10 countries suspended the use of the COVID-19 vaccine by Astra- Zeneca-Oxford University being…

New Delhi: The health ministry said that Supreme Court judges willing to take the COVID-19 vaccine won’t be given a choice between Covishield and Covaxin, rather the process would be entirely through the Co-Win platform. The judges will…